Treating brain metastases involves a multidisciplinary approach that may include surgery, radiation therapy, chemotherapy, targeted therapy, and supportive care. The choice of treatment depends on several factors, including the number, size, and location of the metastases, the patient's overall health, and the primary cancer type. Here are some common treatment options:
- Surgery: Used for tumors that are surgically accessible while causing symptoms from direct compression. The goal of surgery is to reduce the symptoms as well as increase successful response to radiation and medical therapy.
- Stereotactic Biopsy: The goal of a biopsy to attain tissue to identify the type of tumor. It provides the tumor type and other molecular factors to create a treatment plan. However, it does not improve symptoms caused by compression from the tumor.
- Open Surgery: For surgical accessible tumors, surgery can provide immediate decompression of the tissue by removing the tumor. It also reduces the amount of tumor needed to be treated with radiation and medical therapy
- Laser Interstitial Thermal Therapy (LITT): A ultra-minimally invasive approach that provides burning (ablation) of the tumor rather than removal. It does provide immediate death to the tumor but does not assist in taking the pressure of the tumor off. It is best used for difficult to access tumor in sensitive locations.
- Radiation Therapy:
- Stereotactic Radiosurgery (SRS): Delivers a high dose of radiation to a precise target, suitable for a limited number of tumors.
- Whole Brain Radiation Therapy (WBRT): Treats the entire brain, commonly used for multiple metastases and rapidly recurring tumors.
- Chemotherapy: Chemotherapy drugs are designed to target and kill cells that grow and divide rapidly, which is a characteristic of cancer cells. However, this also affects some normal cells that divide quickly, such as those in the hair follicles, bone marrow, and digestive tract.
- Targeted Therapy: Targeted therapy uses drugs or other substances to precisely identify and attack cancer cells, usually by focusing on specific molecules involved in the growth, progression, and spread of cancer. This approach differs from traditional chemotherapy, which generally attacks all rapidly dividing cells, both cancerous and normal. Targeted therapy is effective in cancers with specific genetic mutations (e.g., EGFR, ALK in lung cancer).
- Immunotherapy: Immunotherapy boosts or manipulates the immune system to recognize and destroy cancer cells more effectively. Cancer cells can sometimes evade the immune system by disguising themselves or suppressing immune responses. Immunotherapy aims to overcome these tactics.
- Palliative Care: Palliative care is specialized medical care focused on providing relief from the symptoms and stress of a serious illness. The primary goal is to improve the quality of life for both the patient and their family. It is appropriate for patients of any age and at any stage in a serious illness and can be provided alongside curative treatment.
- Clinical Trials: Participation in clinical trials can provide access to new and experimental treatments.
Factors Influencing Treatment Decisions:
- Number and Size of Metastases: Single or multiple lesions and their size.
- Location of Metastases: Certain brain areas are more critical and sensitive.
- Primary Cancer Type: Different cancers respond differently to various treatments.
- Patient's Overall Health: General health status, age, and comorbidities.
- Previous Treatments: Prior treatments and their outcomes.
Follow-Up and Monitoring:
- Regular imaging (MRI or CT scans) to monitor the effectiveness of treatment.
- Neurological evaluations to assess cognitive function and manage symptoms.
Multidisciplinary Approach:
- Involves oncologists, neurosurgeons, radiation oncologists, neurologists, and supportive care specialists.
Your specific treatment plan often involves a combination of these methods and is tailored to the individual patient’s situation. Regular follow-up and monitoring by your GW Cancer Center multidisciplinary team, including oncologists, neurosurgeons, radiation oncologists, neurologists, and palliative care specialists, are essential to assess the treatment's effectiveness and manage any side effects or complications.
